Orenitram
Manufacturing · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.orenitram.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Orenitram
Orenitram provides oral treprostinil extended release tablets, designed for the treatment of pulmonary arterial hypertension (PAH). Its primary function is to slow the progression of PAH, improve exercise capacity, and alleviate symptoms associated with the condition. The company targets patients suffering from PAH who may benefit from an oral medication as part of their treatment plan. Orenitram also supports its clients with resources for managing treatment, including cost assistance and community support.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Orenitram your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Orenitram, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Orenitram recently announced quarterly report
Product Launch: Get notified when Orenitram launches new products
Check if Orenitram has recently received funding, and reach out quickly before it becomes old news!
Check out if Orenitram is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Orenitram had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Orenitram has new funding data
Congratulate Masked Content for being promoted to Masked Content at Orenitram
Recommended Actions
Find VP level buyers at Orenitram
Find 3 more new buyers
Compare Similar Companies to Orenitram
Compare insights from companies similar to Orenitram, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Company Profile Activity
Activity Insights
Orenitram is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Orenitram is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Orenitram.
Orenitram Tech Stack
A closer look at the technologies used by Orenitram
Orenitram News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Orenitram
Sign Up For FreeTo access detailed company insights
Orenitram provides oral treprostinil extended release tablets, designed for the treatment of pulmonary arterial hypertension (PAH). Its primary function is to slow the progression of PAH, improve exercise capacity, and alleviate symptoms associated with the condition. The company targets patients suffering from PAH who may benefit from an oral medi... Read More
